- Home
- Publications
- Publication Search
- Publication Details
Title
Cell cycle on the crossroad of tumorigenesis and cancer therapy
Authors
Keywords
cell cycle, cancer, metabolism, cancer immune, PROTAC, degradation
Journal
TRENDS IN CELL BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-22
DOI
10.1016/j.tcb.2021.07.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
- (2021) Joyce F. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Spatiotemporal dissection of the cell cycle with single-cell proteogenomics
- (2021) Diana Mahdessian et al. NATURE
- Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
- (2021) Liguo Wang et al. Nature Chemical Biology
- New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy
- (2021) Marina Bury et al. TRENDS IN CELL BIOLOGY
- Cancer Selective Target Degradation by Folate-Caged PROTACs
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
- (2021) Emiliano Maiani et al. NATURE
- The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D
- (2021) Andrea C. Chaikovsky et al. NATURE
- CRL4AMBRA1 is a master regulator of D-type cyclins
- (2021) Daniele Simoneschi et al. NATURE
- TF-PROTACs Enable Targeted Degradation of Transcription Factors
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and independent effects by CDK6-specific PROTACs
- (2020) Marco De Dominici et al. BLOOD
- PROTACs: A novel strategy for cancer therapy
- (2020) Jing Liu et al. SEMINARS IN CANCER BIOLOGY
- Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma
- (2020) Elena Galvani et al. Nature Communications
- PHOTACs enable optical control of protein degradation
- (2020) Martin Reynders et al. Science Advances
- Development of CDK2 and CDK5 Dual Degrader TMX‐2172
- (2020) Nathanael Schiander Gray et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
- (2020) Marcus Ruscetti et al. CELL
- Emerging New Concepts of Degrader Technologies
- (2020) Yu Ding et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle
- (2020) Jing Liu et al. CELL RESEARCH
- The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
- (2020) Mikołaj Słabicki et al. NATURE
- Rational discovery of molecular glue degraders via scalable chemical profiling
- (2020) Cristina Mayor-Ruiz et al. Nature Chemical Biology
- Cell Cycle Regulation Meets Tumor Immunosuppression
- (2020) Jinyang Li et al. TRENDS IN IMMUNOLOGY
- Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
- (2020) M. Caillot et al. Oncogenesis
- First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo
- (2020) Mingming Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
- (2020) Bikash Adhikari et al. Nature Chemical Biology
- Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses
- (2020) Jie Chen et al. Cell Reports
- Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation
- (2020) Lu Lv et al. eLife
- CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
- (2020) Anne Y Lai et al. Journal for ImmunoTherapy of Cancer
- Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
- (2020) Zhen Li et al. Frontiers in Pharmacology
- Selective Degradation of CDK6 by a Palbociclib Based PROTAC
- (2019) Sandeep Rana et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
- (2019) Baishan Jiang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- APC/C-CDH1-regulated IDH3β coordinates with the cell cycle to promote cell proliferation
- (2019) Qingnan Wu et al. CANCER RESEARCH
- Metabolic regulation of cell growth and proliferation
- (2019) Jiajun Zhu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
- (2019) Junya Peng et al. CELL RESEARCH
- Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
- (2019) Shang Su et al. JOURNAL OF MEDICINAL CHEMISTRY
- PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer
- (2019) Carlotta Costa et al. Cancer Discovery
- NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor
- (2019) Marina Bury et al. Cell Reports
- A novel strategy to block mitotic progression for targeted therapy
- (2019) Junlong (Jack) Chi et al. EBioMedicine
- CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
- (2019) Hua Zhang et al. CANCER CELL
- Targeting CDK2 in cancer: challenges and opportunities for therapy
- (2019) Solomon Tadesse et al. DRUG DISCOVERY TODAY
- Development of selective mono or dual PROTAC degrader probe of CDK isoforms
- (2019) Fei Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
- (2018) Meidan Ying et al. BLOOD
- Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
- (2018) Jinyang Li et al. IMMUNITY
- Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia
- (2018) Yue Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
- (2018) Frédéric Lessard et al. NATURE CELL BIOLOGY
- The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
- (2018) David A. Schaer et al. Cell Reports
- Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
- (2018) Jinlei Bian et al. BIOORGANIC CHEMISTRY
- Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
- (2018) Diana Miao et al. NATURE GENETICS
- CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
- (2018) Shom Goel et al. TRENDS IN CELL BIOLOGY
- Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
- (2018) Zhiqiang Li et al. CANCER CELL
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
- (2018) Philipp M. Cromm et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
- (2018) Xin Jin et al. MOLECULAR CELL
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival
- (2017) Haizhen Wang et al. NATURE
- CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
- (2017) Jiehui Deng et al. Cancer Discovery
- CDK Substrate Phosphorylation and Ordering the Cell Cycle
- (2016) Matthew P. Swaffer et al. CELL
- Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
- (2016) C Yang et al. ONCOGENE
- Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation
- (2016) Sushama Kamarajugadda et al. Oncotarget
- The concept of immune surveillance against tumors: The first theories
- (2016) Domenico Ribatti Oncotarget
- FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2015) J. A. Beaver et al. CLINICAL CANCER RESEARCH
- CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance
- (2015) R. Liu et al. MOLECULAR CANCER THERAPEUTICS
- CDK6 as a key regulator of hematopoietic and leukemic stem cell activation
- (2014) Ruth Scheicher et al. BLOOD
- Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
- (2014) Zhaoqing Wang et al. DEVELOPMENTAL CELL
- Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1
- (2014) K. Bhalla et al. DIABETES
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus
- (2014) Pengda Liu et al. NATURE
- A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
- (2013) Karoline Kollmann et al. CANCER CELL
- Mechanisms and function of substrate recruitment by F-box proteins
- (2013) Jeffrey R. Skaar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Control of cell cycle transcription during G1 and S phases
- (2013) Cosetta Bertoli et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- The Spindle Assembly Checkpoint
- (2012) Pablo Lara-Gonzalez et al. CURRENT BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells
- (2011) S. L. Colombo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes
- (2010) S. L. Colombo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases
- (2009) Abdullah Yalcin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction
- (2009) Daming Gao et al. NATURE CELL BIOLOGY
- The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1
- (2009) Angel Herrero-Mendez et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now